Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol)
Open Access
- 7 September 2009
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 68 (3), 422-426
- https://doi.org/10.1111/j.1365-2125.2009.03472.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methodsJoint Bone Spine, 2006
- A multicentre study of coproxamol poisoning suicides based on coroners’ records in EnglandBritish Journal of Clinical Pharmacology, 2004
- Le rôle favorisant de l'Agence française de sécurité sanitaire des produits de santé (Afssaps) dans l'évaluation des médicaments chez l'enfantArchives de Pédiatrie, 2003
- Rates of Spontaneous Reporting of Adverse Drug Reactions in FranceJAMA, 2002
- Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trialClinical Therapeutics, 2001
- Adverse drug reactions: definitions, diagnosis, and managementThe Lancet, 2000
- La pharmacovigilance en pratiqueTransfusion Clinique et Biologique, 1999
- Is reporting rate a good predictor of risks associated with drugs?British Journal of Clinical Pharmacology, 1999
- Acceptability and Efficacy of Two Associations of Paracetamol with a Central Analgesic (Dextropropoxyphene or Codeine): Comparison in OsteoarthritisThe Journal of Clinical Pharmacology, 1992
- Pharmacokinetics of PropoxypheneHuman Toxicology, 1984